Medicine & Life Sciences
Meningococcal Vaccines
100%
Serogroup
62%
Meningococcal Infections
51%
eculizumab
29%
Vaccines
29%
4CMenB vaccine
17%
Complement Factor D
15%
Complement Inactivating Agents
14%
Complement Factor H
13%
Sickle Cell Anemia
10%
Advisory Committees
10%
Centers for Disease Control and Prevention (U.S.)
10%
United States Food and Drug Administration
9%
Italy
9%
Disease Outbreaks
8%
Immunization
8%
Pharmaceutical Preparations
8%
Young Adult
7%
Monoclonal Antibodies
7%
Pediatrics
6%
Antibodies
5%
Arts & Humanities
Vaccine
75%
Person
36%
Dose
17%
Pharmaceuticals
14%
Cheshire
11%
Sickles
11%
Pediatrics
11%
Immunization
10%
Food and Drug Administration
10%
Cleavage
9%
Young Adults
9%
Deficiency
8%
Persistence
7%
Subsidiaries
7%
Italy
6%
Cells
6%